Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1995
09/14/1995WO1995024478A1 Synthetic proteins as implantables
09/14/1995WO1995024477A1 Human papillomavirus targeted ribozymes
09/14/1995WO1995024474A1 Bone morphogenic protein-10
09/14/1995WO1995024473A1 Vascular endothelial growth factor 2
09/14/1995WO1995024469A1 Extracorporeal cell culture and transplantation kits
09/14/1995WO1995024466A1 Transforming growth factor alpha h1
09/14/1995WO1995024427A1 Hybrid human/animal factor viii
09/14/1995WO1995024426A1 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins
09/14/1995WO1995024425A1 Immunomodulatory trichinella substances
09/14/1995WO1995024424A1 Cyclic peptide lhrh antagonists
09/14/1995WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995WO1995024421A1 Peptide derivative
09/14/1995WO1995024418A1 Method of isolating and purifying a biomacromolecule
09/14/1995WO1995024417A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof
09/14/1995WO1995024414A1 Fibroblast growth factor-10
09/14/1995WO1995024411A1 Corpuscles of stannius protein, stanniocalcin
09/14/1995WO1995024223A1 Inhibition of cell proliferation by e2f-1 antisense oligonucleotides
09/14/1995WO1995024221A1 Bioactive and/or targeted dendrimer conjugates
09/14/1995WO1995024220A1 Bispecific molecules having clinical utilities
09/14/1995WO1995024217A1 Methods for modulating t cell unresponsiveness
09/14/1995WO1995024216A1 Prevention of diabetes
09/14/1995WO1995024213A1 Method of stimulating hematopoiesis with hemoglobin
09/14/1995WO1995024212A1 The use of interferon subtypes in the preparation of medicaments to treat viral infections
09/14/1995WO1995024211A1 Use of fibroblast growth factors to stimulate bone growth
09/14/1995WO1995024210A1 Methods and compositions for treatment of periodontal disease and repair of periodontal lesions
09/14/1995WO1995024209A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
09/14/1995WO1995024208A1 Glioblastoma-derived angiogenesis inhibiting factor
09/14/1995WO1995024207A1 Composition for the treatment of lung disease
09/14/1995WO1995024202A1 Ribozyme therapy for restenosis
09/14/1995WO1995024198A1 DIROFILARIA IMMITIS Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF
09/14/1995WO1995024183A1 Methods and compositions for pulmonary delivery of insulin
09/14/1995WO1995024182A1 Human osteoclast-derived cathepsin
09/14/1995WO1995015177A3 Improved efficacy of alpha-helical cytokines
09/14/1995DE4408116A1 New viprolide derivs.
09/14/1995CA2443236A1 Human osteoclast-derived cathepsin
09/14/1995CA2414016A1 Vascular endothelial growth factor 2
09/14/1995CA2185327A1 Hybrid human/animal factor viii
09/14/1995CA2185212A1 Peptide derivatives
09/14/1995CA2185162A1 Compositions for the inhibition of tnf formation and uses thereof
09/14/1995CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/14/1995CA2185027A1 Methods for modulating t cell unresponsiveness
09/14/1995CA2184989A1 Ribozyme therapy for restenosis
09/14/1995CA2184988A1 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins
09/14/1995CA2184905A1 Corpuscles of stannius protein, stanniocalcin
09/14/1995CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995CA2184686A1 Transgenic production of oligosaccharides and glycoconjugates
09/14/1995CA2184583A1 Transforming growth factor alpha h1
09/14/1995CA2184498A1 Extracorporeal cell culture and transplantation kits
09/14/1995CA2184385A1 Composition for the treatment of lung disease
09/14/1995CA2184358A1 Glioblastoma-derived angiogenesis inhibiting factor
09/14/1995CA2183963A1 Dirofilaria immitis gp29 proteins, nucleic acid molecules and uses thereof
09/14/1995CA2183961A1 Fibroblast growth factor-10
09/14/1995CA2183898A1 Nucleotide or nucleosidephotoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
09/14/1995CA2183644A1 Synthetic proteins as implantables
09/14/1995CA2182800A1 Method of stimulating hematopoiesis with hemoglobin
09/14/1995CA2180353A1 Antimicrobial proteins from aralia and impatiens
09/13/1995EP0671472A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody
09/13/1995EP0671470A2 Trehalose releasing enzyme, DNA encoding therefor, their preparation and uses
09/13/1995EP0671414A1 Antithrombotic
09/13/1995EP0671413A1 Somatostatin analogs for preventing NSAID-induced ulcers
09/13/1995EP0671412A1 Tumor cell invasion-inhibiting peptides and cancer metastasis inhibitors
09/13/1995EP0671390A2 Antithrombotic agents
09/13/1995EP0671165A2 Collagen-based injectable drug delivery system and its use
09/13/1995EP0671161A1 Ectoine and ectoine derivatives as moisturizing agents in cosmetic preparation
09/13/1995EP0671004A1 Allergen/inflammatory testing and diagnosis
09/13/1995EP0670904A1 Vector for the expression of therapy-relevant genes
09/13/1995EP0670899A1 Heat shock proteins and the treatment of tumours
09/13/1995EP0670898A1 Interleukin-3 (il-3) mutant polypeptides
09/13/1995EP0670897A1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE
09/13/1995EP0670896A1 Cloning and expression of biologically active alpha-galactosidase a
09/13/1995EP0670895A1 Cloning, expression and uses of a novel secreted protein, f-spondin
09/13/1995EP0670848A1 High molecular weight collagen-like protein polymers
09/13/1995EP0670847A1 Subtilin variant of enhanced stability and activity
09/13/1995EP0670738A1 Methods for enhancing vascularization of implant devices
09/13/1995EP0670737A1 In vivo peptide therapy
09/13/1995EP0670734A1 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen
09/13/1995EP0670733A1 Compositions containing growth factors and antiplastic agents
09/13/1995EP0670732A1 Compositions containing growth factors and antimetabolites
09/13/1995EP0670731A1 AMELIORATION OF AMNESIA IN ALZHEIMER'S DISEASE CAUSED BY DEPOSITION OF AMYLOID $g(b) PROTEIN
09/13/1995EP0670730A1 Fusion proteins comprising tumor necrosis factor receptor
09/13/1995EP0670729A1 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
09/13/1995EP0670728A1 Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design
09/13/1995EP0670727A1 Compounds that inhibit t cell proliferation and methods using the same
09/13/1995EP0670711A1 Mouthcare compositions
09/13/1995EP0542869B1 Tissue plasminogen activator variants with decreased clearance
09/13/1995EP0475936B1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex
09/13/1995EP0383770B1 Inhibition of eucaryotic pathogens and neoplasms with lytic peptides
09/13/1995CN1108261A New pseudopeptides having an antiviral action
09/13/1995CN1108138A Pharmaceutical using of bradykinin-antagonist in preparation of drug for treating viral illness
09/13/1995CN1108137A Pharmaceutical compositions
09/12/1995US5449798 Phospholipid derivatives containing higher elements of the fifth group
09/12/1995US5449778 Peptide intermediates
09/12/1995US5449766 DNA encoding NEI and NGE peptides
09/12/1995US5449765 DNA encoding amino acids 590-710 of glycoprotein gII of pseudorabies virus
09/12/1995US5449760 Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
09/12/1995US5449759 Hemoglobins with intersubunit desulfide bonds
09/12/1995US5449757 Mammalian adipogenic factors
09/12/1995US5449755 Human cyclin E
09/12/1995US5449753 Autotaxin: motility stimulating protein useful in cancer diagnosis
09/12/1995US5449752 Polypeptides with affinity to lipopolysaccharides and their uses